[Management of arrhythmia in patients with arterial hypertension]

Klinicheskaia Meditsina
|September 25, 2012
PubMed

Insights

This study assessed cardiovascular medication risks for arrhythmia in 123 hypertension and atrial fibrillation patients. Beta-blockers, ACE inhibitors, and preductal therapy showed potential in reducing atrial fibrillation and ventricular arrhythmia risks.

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Arterial hypertension and atrial fibrillation are common conditions associated with increased risk of cardiovascular events.
  • Arrhythmic complications pose a significant threat to patients with these conditions.
  • Understanding the impact of cardiovascular medications on arrhythmia risk is crucial for effective patient management.

Purpose of the Study:

  • To estimate the risk of arrhythmic complications associated with cardiovascular medications in patients with arterial hypertension and recurrent atrial fibrillation.
  • To investigate the role of P wave dispersion and QT interval in patients with different types of left ventricular hypertrophy.
  • To evaluate the efficacy of beta-blockers, ACE inhibitors, and preductal therapy in mitigating the risk of atrial fibrillation and ventricular arrhythmia.

Main Methods:

  • Prospective study design involving 123 patients.
  • Assessment of P wave dispersion and QT interval characteristics.
  • Analysis of therapeutic effects of beta-blockers, ACE inhibitors, and preductal agents.

Main Results:

  • Cardiovascular medications were evaluated for their association with arrhythmic complications.
  • Dispersion characteristics were analyzed in relation to left ventricular remodeling.
  • The study identified potential benefits of specific therapies in reducing arrhythmia risk.

Conclusions:

  • Certain cardiovascular medications may influence the risk of arrhythmic complications in hypertensive patients with atrial fibrillation.
  • Left ventricular remodeling characteristics are relevant to arrhythmia risk assessment.
  • Beta-blockers, ACE inhibitors, and preductal therapy warrant further investigation for their anti-arrhythmic potential.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...